Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alimentiv Acquires McDougall Scientific | Contract Pharma
Breaking News

Alimentiv Acquires McDougall Scientific

Niche CRO specializes in statistical analysis, data management, reporting, and clinical trial design.

Alimentiv, Inc., a specialized global gastrointestinal CRO, has acquired McDougall Scientific Ltd., a niche CRO specializing in statistical analysis, data management, reporting, and clinical trial design.
 
“McDougall Scientific has for 35 years prioritized excellence in science through delivery of high quality statistical and data management services. We are thrilled to invite the McDougall organization into the Alimentiv family of companies and are eager to leverage our complementary capabilities to provide an enhanced level of services to our sponsors,” said Jeff Smith, CEO, Alimentiv.

John Amrhein, Vice President of McDougall Scientific who will assume additional responsibilities as Managing Director following the acquisition said, “The expertise of Alimentiv and McDougall Scientific are well aligned to enhance both the scope and depth of service offerings to the clients of both companies.  Our shared values, emphasis on quality, and complementary corporate culture inspired this acquisition that will facilitate synergistic growth and expansion of services.”
 
Combined the companies have offices in London, ON; Toronto, ON; San Diego, USA; and Amsterdam, the Netherlands serving customers worldwide.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters